Operation buyout: KKR, TPG, and other PE firms eye purchase of India's largest cardiac stent maker SMT

Morgan Stanley PE Asia and Samara Capital collectively own 49% of the company while Kotak Pre IPO Opportunities Fund holds 6%. The Kotadias, the company's promoters, own the remaining 45%.